Drug CategoryDrugIHD Dosing

Administration Timing Around HD Session

AntiplateletsASANormal dose based on indicationAdminister Post-HD

Molecular Weight    (Da)

Excreted Unchanged (%)Normal Half-Life (Hours)ESRD Half-Life (Hours)Plasma Protein Binding (%)Volume of Distribution (L/kg)Dialytic Plasma Clearance (ml/min)% Dialyzed
180(Hepatic)2-3Unchanged80-900.1-0.2N/A50-100 (N/A)


  • Aronoff GR, Bennett WM, Berns JS, Brier ME, Kasbekar N, Mueller BA, et al. Drug Prescribing in Renal Failure. Philadelphia: American College of Physicians;2007.
  • DrugBank [Online]. 2012 Apr 12 [cited 2012 May 6]; Available from: URL:
  • Kilickesmez K, Kocas C, Okcun B, et al. Laboratory signs of aspirin response in haemodialysis patients. Scandinavian journal of clinical and laboratory investigation. 2011;71(5):426-31.